The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels
ABSTRACTS
Experimental autoimmune encephalomyelitis (EAE) mice were administered with murine anti-CD52 antibody to investigate its therapeutic effect and whether the treatment modulates IL-33 and ST2 expression. EAE severity and central nervous system (CNS) inflammation were reduced following the treatment, which was accompanied by peripheral T and B lymphocyte depletion and reduced production of various cytokines including IL-33, while sST2 was increased. In spinal cords of EAE mice, while the number of IL-33+ cells remained unchanged, the extracellular level of IL-33 protein was significantly reduced in anti-CD52 antibody treated mice compared with controls. Furthermore the number of ST2+ cells in the spinal cord of treated EAE mice was downregulated due to decreased inflammation and immune cell infiltration in the CNS. These results suggest that treatment with anti-CD52 antibody differentially alters expression of IL-33 and ST2, both systemically and within the CNS, which may indicate IL-33/ST2 axis is involved in the action of the antibody in inhibiting EAE.
Graphical abstract
KEY WORDS
Multiple sclerosis; Experimental autoimmune encephalomyelitis; CD52; IL-33; ST2.
SCREENSHOT
RELATED PRODUCTS
MOG 35–55
CHAINING
https://www.sciencedirect.com/science/article/pii/S0165572817304575
Number of Residues: | 21 |
1-Letter Code: | MEVGWYRSPFSRVVHLYRNGK |
3-Letter Code: | Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys |
Molecular weight (Mr): | 2581.99 g/mol |
Isoelectric point: | 10.6 |
Net charge at pH 7.0: | 3.1 |
Average hydrophilicity: | -0.1 |
Ratio of hydrophilic residues / total number of residues: | 38 % |
评论
发表评论